Literature DB >> 34925573

WOMEN AND MEN WITH CANCER AND A FUTURE DESIRE FOR CHILDREN - WHAT SHOULD CLINICIANS CONSIDER IN COVID-19 PANDEMIC TIMES?

S Findeklee1, M Kasoha2, J C Radosa2, M P Radosa3, B Haj Hamoud2, R M Sima4.   

Abstract

The topic of fertility preservation has been gaining increasing importance since the beginning of this century. The reasons for this development are the advances in oncological therapy over the past few decades, with cure rates of approximately over 90%, and the fact that starting families is increasingly postponed in later periods of life in industrialized countries. Since March 2020 the whole medical and non-medical world experiences a pandemic due to Covid-19 (coronavirus disease 2019) which has never been seen before. This created a plenty of challenges for both, the patients and healthcare providers. This review article presents the fertility-protective methods currently available for women and men suffering from cancer with their clinical approach, value, advantages and disadvantages. Besides, it focuses on the changes and special considerations which have to be taken into account during pandemic times including preventive measures as well as the patient's access to the fertility preserving options. In conclusion every premenopausal woman and every man with incomplete family planning suffering from cancer should be counselled about the existing fertility preserving techniques before commencing cancer therapy. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  Covid-19 pandemic; female fertility preservation; fertility preserving methods; male fertility preservation; oncofertility

Year:  2021        PMID: 34925573      PMCID: PMC8665243          DOI: 10.4183/aeb.2021.234

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  28 in total

Review 1.  Long-term survivors of childhood, adolescent and young adult non-Hodgkin lymphoma.

Authors:  Matthew J Ehrhardt; Jessica Hochberg; Kari L Bjornard; Tara M Brinkman
Journal:  Br J Haematol       Date:  2019-02-03       Impact factor: 6.998

2.  COVID-19 and human reproduction: A pandemic that packs a serious punch.

Authors:  George Anifandis; Helen G Tempest; Rafael Oliva; Grace M Swanson; Mara Simopoulou; Charles A Easley; Michael Primig; Christina I Messini; Paul J Turek; Peter Sutovsky; Steve J Ory; Stephen A Krawetz
Journal:  Syst Biol Reprod Med       Date:  2021-02       Impact factor: 3.061

3.  The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells.

Authors:  Aytac Yuksel; Gamze Bildik; Filiz Senbabaoglu; Nazli Akin; Macit Arvas; Fehmi Unal; Yagmur Kilic; Isil Karanfil; Baldan Eryılmaz; Pelin Yilmaz; Can Ozkanbaş; Cagatay Taskiran; Senai Aksoy; Yılmaz Guzel; Basak Balaban; Umit Ince; Akira Iwase; Bulent Urman; Ozgur Oktem
Journal:  Hum Reprod       Date:  2015-10-13       Impact factor: 6.918

Review 4.  Clinical implications and economic effects of the Coronavirus pandemic on gynecology, obstetrics and reproductive medicine in Germany: learning from Italy.

Authors:  Sebastian Findeklee; Emanuela Morinello
Journal:  Minerva Ginecol       Date:  2020-05-13

Review 5.  Vitrification of embryos and oocytes for fertility preservation in cancer patients.

Authors:  Keiichi Kato
Journal:  Reprod Med Biol       Date:  2016-02-29

Review 6.  Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

Authors:  S Findeklee; L Lotz; K Heusinger; I Hoffmann; R Dittrich; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-12       Impact factor: 2.915

7.  Impaired spermatogenesis in COVID-19 patients.

Authors:  Honggang Li; Xingyuan Xiao; Jie Zhang; Mohammad Ishraq Zafar; Chunlin Wu; Yuting Long; Wei Lu; Feng Pan; Tianqing Meng; Kai Zhao; Liquan Zhou; Shiliang Shen; Liang Liu; Qian Liu; Chengliang Xiong
Journal:  EClinicalMedicine       Date:  2020-10-23

Review 8.  Fertility preservation during the COVID-19 pandemic: mitigating the viral contamination risk to reproductive cells in cryostorage.

Authors:  Satish K Adiga; Prathima Tholeti; Shubhashree Uppangala; Guruprasad Kalthur; Roberto Gualtieri; Riccardo Talevi
Journal:  Reprod Biomed Online       Date:  2020-09-15       Impact factor: 3.828

9.  COVID-19 and fertility: a virtual reality.

Authors:  George Anifandis; Christina I Messini; Alexandros Daponte; Ioannis E Messinis
Journal:  Reprod Biomed Online       Date:  2020-05-08       Impact factor: 3.828

10.  No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019.

Authors:  Feng Pan; Xingyuan Xiao; Jingtao Guo; Yarong Song; Honggang Li; Darshan P Patel; Adam M Spivak; Joseph P Alukal; Xiaoping Zhang; Chengliang Xiong; Philip S Li; James M Hotaling
Journal:  Fertil Steril       Date:  2020-04-17       Impact factor: 7.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.